Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.

Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, Young LT, Yatham LN, Cervantes P.

Bipolar Disord. 2015 Feb;17(1):86-96. doi: 10.1111/bdi.12233. Epub 2014 Jul 21.

PMID:
25046246
2.

Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.

Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, Esposito-Smythers C, Goldstein T, Ryan N, Keller M.

Am J Psychiatry. 2009 Jul;166(7):795-804. doi: 10.1176/appi.ajp.2009.08101569. Epub 2009 May 15.

3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
5.

Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders.

Birmaher B, Gill MK, Axelson DA, Goldstein BI, Goldstein TR, Yu H, Liao F, Iyengar S, Diler RS, Strober M, Hower H, Yen S, Hunt J, Merranko JA, Ryan ND, Keller MB.

Am J Psychiatry. 2014 Sep;171(9):990-9. doi: 10.1176/appi.ajp.2014.13121577.

6.

A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME].

Parikh SV, Zaretsky A, Beaulieu S, Yatham LN, Young LT, Patelis-Siotis I, Macqueen GM, Levitt A, Arenovich T, Cervantes P, Velyvis V, Kennedy SH, Streiner DL.

J Clin Psychiatry. 2012 Jun;73(6):803-10. doi: 10.4088/JCP.11m07343.

PMID:
22795205
7.

The long-term natural history of the weekly symptomatic status of bipolar I disorder.

Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB.

Arch Gen Psychiatry. 2002 Jun;59(6):530-7.

PMID:
12044195
8.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
9.

Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder.

Stange JP, Sylvia LG, Magalhães PV, Frank E, Otto MW, Miklowitz DJ, Berk M, Nierenberg AA, Deckersbach T.

J Psychiatr Res. 2013 Oct;47(10):1329-36. doi: 10.1016/j.jpsychires.2013.05.016. Epub 2013 Jun 21.

10.

A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change.

Ball JR, Mitchell PB, Corry JC, Skillecorn A, Smith M, Malhi GS.

J Clin Psychiatry. 2006 Feb;67(2):277-86.

PMID:
16566624
11.

Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial.

Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, Dickinson LM, Howe ME, Garber J.

Bipolar Disord. 2011 Feb;13(1):67-75. doi: 10.1111/j.1399-5618.2011.00890.x.

12.

Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.

Medda P, Mauri M, Fratta S, Ciaponi B, Miniati M, Toni C, Dell'Osso L, Perugi G.

J ECT. 2013 Sep;29(3):179-88. doi: 10.1097/YCT.0b013e3182887b7a.

PMID:
23899721
13.

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L.

BMC Psychiatry. 2011 Oct 28;11:171. doi: 10.1186/1471-244X-11-171.

14.

Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.

Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH; BRIDGE Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):791-8. doi: 10.1001/archgenpsychiatry.2011.87.

PMID:
21810644
15.

Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: a randomized clinical trial.

West AE, Weinstein SM, Peters AT, Katz AC, Henry DB, Cruz RA, Pavuluri MN.

J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1168-78, 1178.e1. doi: 10.1016/j.jaac.2014.08.013. Epub 2014 Sep 8.

16.

Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.

Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S; EDHIPO Group (Hypomania Detection Study Group).

J Affect Disord. 2008 Apr;107(1-3):169-74. Epub 2007 Sep 17.

PMID:
17870184
17.

Making sense of DSM-5 mania with depressive features.

Reinares M, Bonnín Cdel M, Hidalgo-Mazzei D, Undurraga J, Mur M, Nieto E, Sáez C, Vieta E.

Aust N Z J Psychiatry. 2015 Jun;49(6):540-9. doi: 10.1177/0004867415585583. Epub 2015 May 5.

PMID:
25943979
18.

The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Tohen M, Zarate CA Jr, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ.

Am J Psychiatry. 2003 Dec;160(12):2099-107.

PMID:
14638578
19.

Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.

Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS.

Am J Psychiatry. 2009 Feb;166(2):173-81. doi: 10.1176/appi.ajp.2008.08050746. Epub 2009 Jan 2.

PMID:
19122008
20.

Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.

Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, Solomon DA, Coryell W, Maser JD, Keller MB.

Arch Gen Psychiatry. 2005 Dec;62(12):1322-30.

PMID:
16330720
Items per page

Supplemental Content

Write to the Help Desk